AVH.AX: Summary for AVITA MED FPO - Yahoo Finance

Australia Markets closed

Avita Medical Limited (AVH.AX)


ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.09-0.01 (-5.00%)
At close: 4:10PM AEDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous close0.10
Open0.10
Bid0.09 x
Ask0.10 x
Day's range0.09 - 0.10
52-week range0.09 - 0.15
Volume251,869
Avg. volume292,216
Market cap68.21M
Beta0.67
PE ratio (TTM)-6.33
EPS (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire9 days ago

    Avita Announces Receipt of $975K R&D Tax Incentive

    VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England--(BUSINESSWIRE)-- Avita Medical Limited (ASX: AVH ) (OTCQX: AVMXY ), a regenerative medicine company focused on the treatment of wounds and skin ...

  • Business Wire18 days ago

    Avita Medical Announces Last Patient Visit in U.S. Pivotal Trial

    OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects, has collected long-term follow-up data from the final patient enrolled in its pivotal FDA trial of the ReCell® Autologous Cell Harvesting Device for the treatment of burns, and achieved a key milestone in its U.S. regulatory pathway, the Company said today. The Company now has the necessary clinical data to conduct the analyses needed for a Premarket Approval (PMA) application.

  • Business Wire24 days ago

    Avita Medical Named to 2017 OTCQX Best 50

    VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England--(BUSINESSWIRE)-- Avita Medical Limited (ASX: AVH ) (OTCQX: AVMXY ), a regenerative medicine company focused on the treatment of wounds and skin ...